LI-RADS: a glimpse into the future

Autor: An Tang, Claude B. Sirlin, Mustafa R. Bashir, Ania Z. Kielar
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Treatment response
Carcinoma
Hepatocellular

Unification
Process (engineering)
Hepatocellular carcinoma
Urology
Contrast Media
Diagnostic system
Practice guidelines
030218 nuclear medicine & medical imaging
Scientific evidence
Diagnosis
Differential

Cholangiocarcinoma
03 medical and health sciences
0302 clinical medicine
Diagnosis
Medicine
Humans
Radiology
Nuclear Medicine and imaging

Tomography
Liver imaging
Ultrasonography
Neoplasm Staging
Radiological and Ultrasound Technology
Scope (project management)
business.industry
Carcinoma
Liver Neoplasms
Gastroenterology
Screening and surveillance
Hepatocellular
Data science
Magnetic Resonance Imaging
X-Ray Computed
Expert opinion
Population Surveillance
Differential
Diagnostic imaging
030211 gastroenterology & hepatology
business
Tomography
X-Ray Computed

Algorithms
Forecasting
Zdroj: Sirlin, CB; Kielar, AZ; Tang, A; & Bashir, MR. (2018). LI-RADS: a glimpse into the future. ABDOMINAL RADIOLOGY, 43(1), 231-236. doi: 10.1007/s00261-017-1448-1. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/25h5s9td
Abdominal radiology (New York), vol 43, iss 1
Popis: This article provides a glimpse into the future of the Liver Imaging Reporting and Data System (LI-RADS), discussing the immediate and long-term plans for its continuing improvement and expansion. To complement the Core and Essentials components of the latest version of LI-RADS, a comprehensive manual will be released soon, and it will include technical recommendations, management guidance, as well as reporting instructions and templates. In this article, we briefly review the process by which LI-RADS has been developed until now, a process guided by a variable combination of data, expert opinion, and desire for congruency with other diagnostic systems in North America. We then look forward, envisioning that forthcoming updates to LI-RADS will occur regularly every 3 to 5 years, driven by emerging high-quality scientific evidence. We highlight some of the key knowledge and technology gaps that will need to be addressed to enable the needed refinements. We also anticipate future expansions in scope to meet currently unaddressed clinical needs. Finally, we articulate a vision for eventual unification of imaging system for HCC screening and surveillance, diagnosis and staging, and treatment response assessment.
Databáze: OpenAIRE